Case report · 10 Aug 2026
Research articlePublished 2019
Clinical and Hemodynamic Effect of Sildenafil in Patients with Left Sided Heart Failure Complicated with Pulmonary Hypertension
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: The prognostic role of Pulmonary arterial hypertension (PH) and RV dysfunction in LV HF provides the rationale for targeting PH as a new option in both HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF). Therefore, we conducted the present randomized controlled trial in order to assess the clinical and hemodynamic effects of sildenafil in patients with left-sided HF complicated with PH. Methods: The current study enrolled 120 patients who were randomly divided into Sildenafil group included 60 patients received sildenafil therapy in addition to standard treatment of HF and control group included 60 patients received standard treatment of HF only. All patients had left sided HF complicated with severe PH. Results: Notably, at six months of follow-up, the sildenafil led to statistically significant improvements in the 6 MWT; this improvement was significantly higher in Sildenafil group than control group and patients on sildenafil had a significantly higher frequency of NYHA’s improvement (41(71.9%) vs.16(29.1%); P=0.01) in comparison to the control group. In addition sildenafil led to a higher reduction in mPAP than the control group (p=0.02). Conclusion: Sildenafil is safe and an effective treatment option for patients with left-sided HF complicated by PH.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Trials.
Short communication · 31 Jul 2026
Understanding Bioavailability as a Key Element in Effective Therapeutic Delivery
Research article · 14 Jun 2026
Ensuring Rights and Dignity in Ethical Practices of Clinical Studies with Vulnerable Group and Safeguarding Vulnerable Group Act (2006)
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Saud M Elsaughier”
- BylineArticles whose byline prints “Mohamed Kamal Slama”
- BylineArticles whose byline prints “Naggeh M Mahmoud”
- BylineArticles whose byline prints “Ramadan Ghaleb”
- BylineArticles whose byline prints “Elham Abdelmonam”
